Diasorin Spa Stock Return On Asset

34D Stock  EUR 105.20  2.40  2.23%   
DiaSorin SpA fundamentals help investors to digest information that contributes to DiaSorin SpA's financial success or failures. It also enables traders to predict the movement of DiaSorin Stock. The fundamental analysis module provides a way to measure DiaSorin SpA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DiaSorin SpA stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

DiaSorin SpA Company Return On Asset Analysis

DiaSorin SpA's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current DiaSorin SpA Return On Asset

    
  0.0902  
Most of DiaSorin SpA's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DiaSorin SpA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, DiaSorin SpA has a Return On Asset of 0.0902. This is 101.03% lower than that of the Healthcare sector and 101.2% lower than that of the Diagnostics & Research industry. The return on asset for all Germany stocks is 164.43% lower than that of the firm.

DiaSorin Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DiaSorin SpA's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DiaSorin SpA could also be used in its relative valuation, which is a method of valuing DiaSorin SpA by comparing valuation metrics of similar companies.
DiaSorin SpA is currently under evaluation in return on asset category among its peers.

DiaSorin Fundamentals

About DiaSorin SpA Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze DiaSorin SpA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DiaSorin SpA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DiaSorin SpA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in DiaSorin Stock

DiaSorin SpA financial ratios help investors to determine whether DiaSorin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.